Abdelhamid S, Lewicka S, Bige K, Haack D, Lorenz H, Nensel U, Röckel A, Fiegel P, Walb D, Vecsei P
Hypertension and Nephrology Unit, Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
J Steroid Biochem Mol Biol. 1994 Sep;50(5-6):319-27. doi: 10.1016/0960-0760(94)90138-4.
21-Deoxyaldosterone has been postulated to be a precursor of aldosterone in an alternative biosynthesis pathway and Kelly's-M1 is considered to be its metabolite. In healthy volunteers, the excretion rate of 21-deoxyaldosterone and of Kelly's-M1 are significantly lower than the aldosterone metabolites, aldosterone-18-glucuronide and tetrahydro-aldosterone and than the aldosterone precursor 18-OH-corticosterone. Essential hypertension patients (with low and normal renin) excrete comparable values of 21-deoxyaldosterone and Kelly's-M1 as normotensives. In 66% of aldosterone-producing adenoma cases (APA) and in 60% of idiopathic hyperaldosteronism (IHA) patients, significantly raised values of 21-deoxyaldosterone and Kelly's-M1 were found. The patients with the high excretion rates of both steroids showed only moderately increased values of the aldosterone metabolites, aldosterone-18-glucuronide and tetrahydro-aldosterone, as well as of the aldosterone precursor 18-OH-corticosterone. In contrast, the latter mentioned steroids were excreted in higher amounts in those patients with normal excretion of 21-deoxyaldosterone and Kelly's-M1. Hence, it is suggested that aldosterone is produced alternatively either via 18-OH-corticosterone alone or additionally via 21-deoxyaldosterone. Furthermore, in three cases of "incidentally" discovered adrenal adenomas, 21-deoxyaldosterone and Kelly's-M1 were the only elevated steroids. After adrenalectomy, excretion of 21-deoxyaldosterone and of Kelly's-M1 and blood pressure returned to normal, which proves that these steroids play a role in blood pressure regulation. In essential hypertension, ACTH infusion induced a significant increase of 21-deoxyaldosterone and Kelly's-M1. However, the increase after angiotensin II was 3- to 6-fold higher than after ACTH. IHA patients proved to be more responsive to angiotensin II; and, in contrast, APA cases proved to be more sensitive to ACTH. The data suggest that beside the main route of aldosterone biosynthesis via 11-deoxycorticosterone, corticosterone and 18-OH-corticosterone an alternative pathway exists via 21-deoxyaldosterone in healthy and in hypertensive patients. There are similarities between the regulation of 21-deoxyaldosterone and the regulation of aldosterone. The determination of 21-deoxyaldosterone and its possible metabolite Kelly's-M1 might be appropriate in the diagnosis of mineralocorticoid-induced forms of hypertension, especially when an adrenal adenoma is discovered.
21-脱氧醛固酮被假定为醛固酮在一条替代生物合成途径中的前体,且凯利氏-M1被认为是其代谢产物。在健康志愿者中,21-脱氧醛固酮和凯利氏-M1的排泄率显著低于醛固酮代谢产物醛固酮-18-葡萄糖醛酸苷和四氢醛固酮,也低于醛固酮前体18-羟皮质酮。原发性高血压患者(肾素水平低和正常)排泄的21-脱氧醛固酮和凯利氏-M1值与血压正常者相当。在66%的醛固酮瘤病例(APA)和60%的特发性醛固酮增多症(IHA)患者中,发现21-脱氧醛固酮和凯利氏-M1值显著升高。两种类固醇排泄率高的患者,其醛固酮代谢产物醛固酮-18-葡萄糖醛酸苷和四氢醛固酮以及醛固酮前体18-羟皮质酮的值仅适度升高。相比之下,在21-脱氧醛固酮和凯利氏-M1排泄正常的患者中,上述提到的类固醇排泄量更高。因此,提示醛固酮可单独通过18-羟皮质酮或额外通过21-脱氧醛固酮产生。此外,在3例“偶然”发现的肾上腺腺瘤病例中,21-脱氧醛固酮和凯利氏-M1是仅升高的类固醇。肾上腺切除术后,21-脱氧醛固酮和凯利氏-M1的排泄以及血压恢复正常,这证明这些类固醇在血压调节中起作用。在原发性高血压中,促肾上腺皮质激素输注导致21-脱氧醛固酮和凯利氏-M1显著增加。然而,血管紧张素II后的增加比促肾上腺皮质激素后的增加高3至6倍。IHA患者对血管紧张素II反应更强;相反,APA病例对促肾上腺皮质激素更敏感。数据表明,在健康和高血压患者中,除了通过1-脱氧皮质酮、皮质酮和18-羟皮质酮的醛固酮生物合成主要途径外,还存在通过21-脱氧醛固酮的替代途径。21-脱氧醛固酮的调节与醛固酮的调节之间存在相似性。测定21-脱氧醛固酮及其可能的代谢产物凯利氏-M1可能适用于诊断盐皮质激素诱导的高血压形式,尤其是在发现肾上腺腺瘤时。